Navacaprant is the company's main product candidate, and was measured using the Montgomery-Åsberg Depression Rating Scale, or MADRS, a 10-question diagnostic questionnaire used by mental-health ...

Neumora Therapeutics' shares tumbled more than 80% on Thursday after its experimental depression drug failed to reduce symptoms such as sadness and pessimistic thoughts in a key study, raising ...

Patients who received the drug, called navacaprant, showed no more improvement in depressive symptoms than people who ...